Prader-Willi syndrome (PWS) is a neurodevelopmental disorder caused by a lack of expression of paternally inherited genes located in the15q11.2-q13 chromosome region. An obstacle in the study of human neurological diseases is the inaccessibility of brain material. Generation of induced pluripotent stem cells (iPSC cells) from patients can partially overcome this problem. We characterized the cellular differentiation potential of iPS cells derived from a PWS patient with a paternal 15q11-q13 deletion. A gene tip transcriptome array revealed very low expression of genes in the 15q11.2-q13 chromosome region, including SNRPN, SNORD64, SNORD108, SNORD109, and SNORD116, in iPS cells of this patient compared to that in control iPS cells. Methylationspecific PCR analysis of the SNRPN gene locus indicated that the PWS region of the paternal chromosome was deleted or methylated in iPS cells from the patient. Both the control and patient-derived iPS cells were positive for Oct3/4, a key marker of pluripotent cells. After 11 days of differentiation into neural stem cells (NSCs), Oct3/ 4 expression in both types of iPS cells was decreased. The NSC markers Pax6, Sox1, and Nestin were induced in NSCs derived from control iPS cells, whereas induction of these NSC markers was not apparent in NSCs derived from iPS cells from the patient. After 7 days of differentiation into neurons, neuronal cells derived from control iPS cells were positive for βIII-tubulin and MAP2. However, neuronal cells derived from patient iPS cells only included a few immunopositive neurons. The mRNA expression levels of the neuronal marker βIII-tubulin were increased in neuronal cells derived from control iPS cells, while the expression levels of βIII-tubulin in neuronal cells derived from patient iPS cells were similar to those of NSCs. These results indicate that iPS cells derived from a PWS patient exhibited neuronal differentiation defects.
Introduction
Prader-Willi syndrome (PWS) is a neurodevelopmental disorder that arises from the lack of expression of paternally inherited genes located on chromosome 15q11-q13 [1] . PWS is characterized by excessive eating behavior and obesity, hypothalamic short stature, hypogonadism, and intellectual disability. There are three main genetic subtypes in PWS: paternal 15q11-q13 deletion (65-75% of cases) [2] , maternal uniparental disomy (20-30%) [3] , and imprinting defects (1-3%) [4] . The maternal uniparental disomy type is due to a paired chromosome 15 of maternal origin. Cases of imprinting defects constitute a rare PWS subtype caused by a lack the expression of genes in the PWS region on the paternal chromosome due to DNA methylation. DNA methylation analysis of the 5′ end of the SNRPN gene [5] , including the promoter region, is widely used for the diagnosis of PWS for all three genetic subtypes. The genetic and expression map of chromosome 15q11. 2-q13 shows that the PWS region contains MNKRN3, MAGEL2 [6, 7] , Necdin [8, 9] , the SNURF-SNRPN gene complex, including the imprinting center (IC), and the small nucleolar RNA (SnoRNA) gene cluster. Angelman syndrome [10] can be caused by the absence of maternal expression of the UBE3 A gene [11] , which is located near the PWS region. The SnoRNA gene cluster encodes untranslated small RNAs. The IC, which is located at the 5′ end of the SNRPN gene, regulates the imprinting of the entire PWS region.
Several diseases have been successfully modeled due to the development of induced pluripotent stem cell (iPSC) technology, including Alzheimer's disease, Parkinson's disease, and Huntington's disease (HD) [12] . Neurological disorders have greatly benefited from iPSC disease modeling due to its capability to generate disease-relevant central nervous system cell types in vitro that would otherwise only be https://doi.org/10.1016/j.neulet.2019.03.029 Received 3 December 2018; Received in revised form 16 March 2019; Accepted 18 March 2019 available from postmortem samples. iPS cells from a PWS patient have also been generated and characterized [13] [14] [15] , but the neuronal differentiation was not studied. Here, we report the neuronal differentiation defects of iPSC derived from a PWS patient with a typical paternal 15q11-q13 deletion. Our findings may help reveal the pathogenetic mechanisms of the neuronal disorders in PWS.
Materials and methods

Human iPSC culture
Normal human iPS cells created from nasal epithelial cells (Nips cells) [16] and iPS cells derived from the PWS patient skin fibroblast (iPWS cells) were provided by RIKEN BioResource Center (Tsukuba, Ibaraki, Japan). Nips and iPWS cells were created with the Sendai virus vector (DNAVEC Inc; Cyto Tune TM-iPS vector) that individually carried each of OCT3/4, SOX2, KLF4, and c-MYC. The iPS cells were maintained in feeder-free conditions and cultured in Cellartis DEF-CS medium (Takara Bio, Inc), containing Cellartis DEF-CS 500 additives (DEF-CS GF-1 and GF-2), on coated dishes with Cellartis DEF-CS COAT-1 (Takara Bio, Inc). The iPS cells were passaged after reaching 70-80% confluence (every 3-5 days). To prevent cell death, the iPS cells were cultured in medium containing the ROCK inhibitor Y27632 (Wako Pure Chemical Industries, Ltd) after cell passage.
Differentiation of iPS cells into neural stem cells (NSCs)
The protocol for the differentiation of iPS cells into NSCs is shown in Fig.1 (i) [17] . iPS cells cultured in feeder-free conditions were split into 6-well plates at a density of 1 × 10 5 cells/well. One day after splitting, the culture medium was changed to PSC neural induction medium (neurobasal medium containing a neural induction supplement, Gibco; Thermo Fisher Scientific, Inc). The medium was changed every 2 days from day 0 to 7. On day 7 of neural induction, primitive NSCs were dissociated with Accutase (StemPro Accutase cell dissociation reagent, Gibco; Thermo Fisher Scientific, Inc) and replated on Geltrex (Gibco; Thermo Fisher Scientific, Inc) coated 6-well plates at 1 × 10 5 cells/well in NSC expansion medium (50% Neurobasal medium, 50% Advanced DMEM/F12 and neural induction supplement). The NSC expansion medium was changed every other day until the cells reached confluence at 4-5 days after plating.
Neuronal differentiation of NSCs
The protocol for differentiation of NSCs into neuronal cells is shown in Fig. 1 (ii). NSCs were cultured on poly-L-ornithine (Sigma-Aldrich Japan)-and laminin (Invitrogen; Thermo Fisher Scientific, Inc) coated 6-well plates at 2 × 10 5 cells/well in complete StemPro NSC SFM medium, which contained Knockout DMEM/F-12, human bFGF, human EGF, and StemPro Neural supplement (Gibco; Thermo Fisher Scientific). After two days, the medium was changed to neurobasal medium containing B27 serum-free supplement, B27 plus supplement, and GlutaMax-I (Gibco; Thermo Fisher Scientific, Inc). The medium was changed every 3 days from day 0 to day 7.
Methylation-specific PCR
Genomic DNA was extracted from Nips and iPWS cells using Nucleo Spin Tissue (Takara Bio, Inc). Bisulfite conversion, which involved converting cytosine into uracil while leaving 5-methylcytosine intact, was used to detect DNA methylation. The following primer sequences from the SNRPN gene were used for methylation-specific PCR amplification. SNRPN-M; 5′-TAAATAAGTACGTTTGCGCGGTC-3′ and 5′-AACCTTACCCGCTCCATCGCG-3′, SNRPN-P; 5′-GTAGGTTGGTGTGT ATGTTTAGGT-3′ and 5′-ACATCAAACATCTCCAACAACCA-3′. The underlined nucleotides indicate those converted after bisulfite modification. SNRPN-M primers were used to detect methylated DNA strands, and SNRPN-P primers were used to detect unmethylated DNA strands. PCR products were separated on 8% polyacrylamide gels.
Real-time RT-PCR analysis of mRNA expression levels
Total RNA was isolated with IsogenⅡ reagent (Nippon Gene Co., Ltd), and cDNA was synthesized from total RNA (1 μg) using a Transcriptor First Strand cDNA Synthesis Kit (Roche Life Science). PCR analyses were performed in a reaction mixture containing 5 μL cDNA in a total volume of 20 μL with SYBR GreenⅠ (LightCycler FastStart DNA MasterPLUS SYBR GreenI, Roche Life Science) on a LightCycler 1.5 (Roche Life Science). The primer sequences are listed in Table 1 .
Immunofluorescence
The cells were fixed with 4% paraformaldehyde (Wako Pure Chemical Industries) for 20 min at room temperature. After washing with phosphate buffered saline (PBS), the cells were permeabilized by adding 0.1% TritonX-100 for 15 min at room temperature. Then, the cells were incubated with primary antibodies against Nestin (1:200, Merck Millipore Corp), Oct4 (1:500, Abcam), βIII-tubulin (1:500, Promega) or MAP2 (1:500, Santa Cruz Biotechnology, Inc) diluted in 5% donkey serum in PBS for 1 h at room temperature. After washing, the cells were incubated with secondary antibodies, including Alexa 488 anti-mouse IgG (1:1000, Molecular Probes; Thermo Fisher Scientific, Inc), Alexa 555 anti-rabbit IgG, or Alexa 555 anti-goat IgG (1:1000, Molecular Probes; Thermo Fisher Scientific, Inc) according to
Fig. 1. Process of deriving NSCs from iPS cells. (i) Derivation of NSCs from iPS cells (iPSCs)
. This simple induction method was performed under feeder free conditions. All cells were induced for more than 11 days (7 days of induction followed by more than 4 days of expansion with an induction supplement). P0 NSCs, NSCs induced from iPS cells at passage 0 (P0); P1 NSCs, P0 NSCs passaged once. (ii) NSC were induced to form neurons for 7 days. Fresh induction medium was added every 3 days. the primary antibody. Cell nuclei were stained with DAPI (300 nM). Photographs were obtained using a fluorescence microscope (EVOS, ThermoFisher, Inc).
Gene tip transcriptome array
Total RNA was extracted from Nips-B2 and iPWS cells using the TRI reagent (Sigma-Aldrich Japan Table 2 were identified as the most significantly low expression genes in iPWS cells compared to control Nips cells with fold change > 10. The selected genes are located in the typical deletion region 15q11-q13 of PWS on paternal chromosome.
Results
Characterization of PWS patient-derived iPS cells
There are three main genetic subtypes of PWS: paternal 15q11-q13 deletion, maternal uniparental disomy and imprinting defects. To examine the characteristics of iPWS cells, we performed a gene tip transcriptome array [18] to analyze the expression of PWS-related genes in Nips and iPWS cells. The expression profile showed highly differentially expressed genes in iPWS cells versus Nips cells ( Table 2 ). The expression of genes on chromosome region 15q11.2-q13, including SNRPN, SNORD64, SNORD108, SNORD109, and SNORD116, was very low in iPWS cells compared to that of control Nips cells. The UBE3 A gene, which is near the PWS region, is maternally expressed and paternally silent. Our data showed that UBE3 A expression in iPWS cells was comparable to that in control cells. We expected that the expression of MAGEL2, NECDIN, and SNORD115 would also be suppressed, but the expression ratios of these genes were not different between control Nips and iPWS cells due to the low expression levels in Nips cells.
Next, we performed a methylation-specific PCR analysis [19] at the SNRPN gene locus. Genomic DNA prepared from Nips and iPWS cells was treated with sodium bisulfite, which converts cytosine to uracil when cytosine is unmethylated, to detect differential methylation at the CpG island of the SNRPN gene.
We used PCR primers specific for the methylated and unmethylated versions of the SNRPN gene sequences. Nips cells exhibited both a 174 bp PCR product from the methylated maternal chromosome and a 100 bp PCR product from the unmethylated paternal chromosome. However, iPWS cells showed only the 174 bp PCR product (Fig. 2) . These results suggest that the PWS region of the paternal chromosome of iPWS cells is deleted or methylated. The expression profile and methylation status of the PWS region of iPWS cells are consistent with the characteristics of PWS.
Characterization of NSCs derived from iPWS cells
Nips and iPWS cells were induced to differentiate into NSCs by exposure to neural stem cell induction medium for 7 days (NSC and PWNSC, respectively). After incubation for 4-5 days in the expansion medium, the cells were analyzed. The NSC markers [20] Pax6 and Sox1 were induced in Nips cells that had differentiated into NSCs (Fig. 3A) . Nestin, another NSC marker, was also moderately induced in Nips cells that had differentiated into NSCs (Fig. 3B and D) . However, no induction of all NSC markers, including Pax6, Sox1, and Nestin, was apparent in PWNSC (Fig. 3A, B and D) [21] . These data suggest iPWS cells are Fig. 2 . Methylation-specific PCR assay. Genomic DNA was prepared from Nips and iPWS cells and then treated with sodium bisulfite, which converts cytosine into uracil when cytosine is unmethylated. PCR primers specific for the methylated and unmethylated versions of the SNRPN gene sequence were used in the methylation-specific PCR assay. A 174 bp PCR product from the methylated maternal chromosome and a 100 bp PCR product from the unmethylated paternal chromosome were detected. Abbreviations in the figure: M, DNA size markers; m, PCR using a maternal primer set only; p, PCR using a paternal primer set only; m + p, multiplex PCR using both maternal and paternal primer sets. An analysis of Nips (normal) cell data is shown in the left side of the panel, and an analysis of iPWS (PWS) cells is shown on the right side. deficient in neural differentiation potential. It is important to mention that the pluripotent cell marker Oct3/4 [22] , which decreased to 1.6% in NSC and 0.2% in PWNSC, was suppressed in both cells (Fig. 3C, D) . These data suggest that iPWS cells changed conditions from iPS cells during the NSC induction process.
Characterization of neuronal cell differentiation from iPWS cells
Differentiation of NSCs from Nips and iPWS cells was induced by culturing cells in neurobasal medium with supplements for 7 days (Fig. 1, ⅱ) . We determined whether iPWS cells could differentiate into neurons by immunofluorescent staining and qRT-PCR. After 7 days of differentiation, neurons derived from control NSCs were positive for the neuronal markers βIII-tubulin and MAP2 [23] . NSC and PWNSC were negative for these markers before neuronal induction (Fig. 4A) . However, neuronal differentiation from iPWS cells showed few immunopositive neurons (Fig. 4A) , and the several neurons were observed in neuronal induced iPWS cells (data not shown). The mRNA expression levels of the neuronal marker βIII-tubulin [24] were increased in neuronal cells that had differentiated from Nips cells, while the cells that had differentiated from iPWS cells showed a similar expression level of βIII-tubulin to NSCs (Fig. 4B) . These results indicate that PWNSC do not express Pax6, Sox1, and Nestin and have limited potential to differentiate into neurons. 
Discussion
Most PWS studies have been performed in mouse models [25] or via MRI of PWS patients [26, 27] . Although, no clear structural abnormalities were reported on MRI scans of nine teenagers with PWS [27] , the brain research has suggested potential effects of growth hormone supplementation in PWS on behavior and cognition [28] . Besides, the consequences of single genes' (or gene clusters') loss of expression on the phenotype are similar to the human PWS features [25] , and deletion of PWS related gene in mouse showed abnormal neuronal hormones secretions [29] . These studies suggest that PWS could have abnormal features in brain and neurons. However, there is no information as to how an early neural differentiation defect may affect neuronal development in PWS patients. In addition, the pathogenic mechanisms of PWS are still not fully understood. Here, we demonstrated neuronal differentiation defects in iPWS cells.
Many gene expressions were suppressed with DNA methylation, which is cytosine methylation, to prevent the interaction of DNA and transcription factors or to induce transcriptional inactivation. In PWS imprinting region, the regulation of gene expressions with DNA methylation was well studied [14, 15, 30, 31] . On the other hand, the expressions of 15q11-q13 deletion genes on paternal chromosome are not correlated with DNA methylation, while maternal genes that paired with paternal 15q11-q13 deletion are methylated. Interestingly, uniparental disomy (UPD) has silencing DNA with methylated CpG sites [32] . We concerned that it may possible to change the methylation conditions of iPWS cells with reprogramming. However, the methylation status of PWS-ICR in nine lines of iPS cells derived from a patient with PWS was reportedly not altered through reprogramming [13] . Our methylation-specific PCR data also suggested that Nips and iPWS cells keep the methylation conditions of CpG island on maternal chromosomes and reflected unmethylated deletion regions of PWS. Our conclusion is methylation conditions of Nips and iPWS cells are unaffected by reprogramming.
In PWS deleted gene, Necdin gene, Magel 2 gene, and Snord116 gene have been well studied with single gene knockout mouse models. The human necdin gene (NDN) is located within the centromeric portion of the PWS deletion region on chromosome 15q11-q13. Because of necdin has the function to represses p53-mediated apoptosis, primary cortical neurons prepared from paternal NDN-deficient mice have high p53 acetylation levels and are sensitive to the DNA damaging compounds camptothecin and hydrogen peroxide [9] . The human MAGEL2 gene is located 41 kB telomeric to NDN, within the PWS deletion region [5] . TheMagel2 gene is expressed in various brain regions, most notably the hypothalamus [33] . The Magel 2 gene deletion impaired hypothalamic production of at least several mature amidated neuropeptides, oxytocin, arginine-vasopressin, and orexin-A [29] . The Snord116 gene, also known as Pwcr1 or MbII-85 in mouse, is one of the C/D box snoRNAs [34] . Interestingly, expression of Snord116 in mice embryo is restricted to neural tissues and that the gene display strikingly similar expression patterns of the NDN and Magel 2 genes in the central nervous system. Additionally, Snord116 is expressed diffusely in the developing brain and spinal cord [35] . Furthermore, the lack of Snord116 in the orexigenic acting neuropeptide Y (NPY) neurons leads to the upregulation of NPY mRNA consistent with the hyperphagic phenotype [36] . Further studies are required to clarify underlying mechanism on how Snord116 regulates the localization and neuronal function. Thus, the 15q11.2-q13 region genes play an important role in brain functions. It is important to compare the neuronal differentiation potential of iPS cells with single gene knockouts and large deletions of the PWS region and to elucidate the mechanism of NSC induction defects.
Conforti described abnormal neural development in HD [12] . This paper suggests early neurodevelopmental defects in HD patients could contribute to the later adult neurodegenerative phenotype. PWS patients are considered to exhibit defects in the neurodevelopmental processes but not in the neuronal differentiation processes. Our data suggest that the pathogenic mechanism of PWS may involve incomplete differentiation into NSCs; however, no major brain structural abnormalities were detected in vivo [27] .
In conclusion, our results provide evidence of neuronal differentiation defects during early neural induction in PWS patients. These findings may help to determine the mechanism of neuronal development disorders in PWS patients.
